Literature DB >> 19196124

Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cells.

Brian Kealy1, Aaron Liew, Jill M McMahon, Thomas Ritter, Aideen O'Doherty, Melissa Hoare, Udo Greiser, Erin E Vaughan, Martin Maenz, Ciara O'Shea, Frank Barry, Timothy O'Brien.   

Abstract

BACKGROUND/AIMS: The ability of endothelial progenitor cells (EPCs) to home to sites of neoangiogenesis makes them attractive candidates for use in the field of gene therapy. The efficacy of this approach depends on the efficiency of the vector used for transgene delivery. METHODS/
RESULTS: In this study, we have compared the efficiency of adenovirus, five serotypes of AAV2, VSVG-pseudotyped lentivirus, and nonviral plasmid/liposome DNA vectors to deliver the green fluorescence protein reporter gene to human early EPCs to determine efficacy and vector-related cell toxicity. Adenovirus proved most effective with efficiencies of up to 80% with low levels of cell death. Lower levels of expression were seen with other vectors. Electroporation proved unsuitable at the parameters tested. We have also identified at least two distinct subpopulations that exist in the heterogeneous parent EPC culture, one of which is amenable to transduction with adenovirus and one that is not. In addition, adenoviral transduction did not disrupt the ability of the cells to incorporate into endothelial structures in vitro.
CONCLUSION: We have found adenovirus to be the most efficient of the vector systems tested for gene delivery to EPCs, an effect that is mediated almost entirely by one of two identified subpopulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196124     DOI: 10.1089/ten.tec.2008.0323

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  7 in total

1.  In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin.

Authors:  John D Stroncek; Yujing Xue; Nabila Haque; Jeffrey H Lawson; William M Reichert
Journal:  Tissue Eng Part A       Date:  2011-05-25       Impact factor: 3.845

2.  Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.

Authors:  Liyan Lin; Juanbing Wei; Yuqing Chen; Aimin Huang; Kay Ka-Wai Li; Wenmin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

3.  MR reporter gene imaging of endostatin expression and therapy.

Authors:  Kai Wang; Kezheng Wang; Baozhong Shen; Tao Huang; Xilin Sun; Weihua Li; Gang Jin; Lin Li; Lihong Bu; Renfei Li; Dan Wang; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2009-12-03       Impact factor: 3.488

4.  Construction and characterization of human embryonic kidney-(HEK)-293T cell overexpressing truncated α4 integrin.

Authors:  Azam Fatahi; Ilnaz Rahimmanesh; Mina Mirian; Fattah Rohani; Maryam Boshtam; Azam Gheibi; Laleh Shariati; Hossein Khanahmad; Shirin Kouhpayeh
Journal:  Res Pharm Sci       Date:  2018-08

5.  Secretion of proteins and antibody fragments from transiently transfected endothelial progenitor cells.

Authors:  Loree Heller; Reynald Thinard; Melanie Chevalier; Sezgi Arpag; Yu Jing; Ruth Greferath; Richard Heller; Claude Nicolau
Journal:  J Cell Mol Med       Date:  2020-07-01       Impact factor: 5.310

Review 6.  Nonviral Gene Therapy for Cancer: A Review.

Authors:  Chiaki Hidai; Hisataka Kitano
Journal:  Diseases       Date:  2018-07-03

Review 7.  Gene therapy for peripheral arterial disease.

Authors:  Rachel Forster; Aaron Liew; Vish Bhattacharya; James Shaw; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2018-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.